USD10
ACOG Shares
About Alpha CognitionAlpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

USD10
ACOG Shares
About Alpha CognitionAlpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Stats

TRADING WINDOW

Closed

OPENS AT

Apr 17 at 1:30 PM GMT+0

MARKET CAP

$144.80M

OPEN PRICE

Not enough data

LOW (1Y)

$4.20

HIGH (1Y)

$11.54

LOW (24H)

$6.54

HIGH (24H)

$6.86

VOLUME (24H)

$53.67K

13.89%

Price history

Time
Price
Change
Today
Not enough data
Not enough data
1 Day
$6.66
0.10%
1 Week
$6.44
3.34%
1 Month
$5.76
15.55%
1 Year
$4.21
57.96%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.